STC
IPXL

SEI Trust Company’s Impax Laboratories, Inc. IPXL Stock Holding History

SEI Trust Company’s Portfolio IPXL Stock Details IPXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-2,052
Closed -$52K – 1712
2013
Q4 		$52K Sell
2,052
-2,048
-50% -$45.7K ﹤0.01% 1583
2013
Q3 		$84K Hold
4,100
– – ﹤0.01% 1454
2013
Q2 		$82K Buy
+4,100
New +$72.8K ﹤0.01% 1381

Other funds holding IPXL

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

SEI Trust Company's IPXL Position: Q1 2014 in Review

SEI Trust Company sold out of Impax Laboratories, Inc. (IPXL) in Q1 2014, closing a stake of 2,052 shares — an estimated $52K sold.

SEI Trust Company first reported a position in IPXL in Q2 2013 and held it in 3 quarters. The position peaked at $84K in Q3 2013. 181 funds tracked by Wall St. Rank hold IPXL as of Q1 2014.

  • SEI Trust Company reported no remaining Impax Laboratories, Inc. position as of Q1 2014 after selling out during the quarter.
  • SEI Trust Company sold 2,052 Impax Laboratories, Inc. shares in Q1 2014, an estimated $52K.
  • SEI Trust Company first reported a position in Impax Laboratories, Inc. in Q2 2013 and held it in 3 quarters.
  • SEI Trust Company's Impax Laboratories, Inc. position peaked at $84K in Q3 2013.
  • 181 funds tracked by Wall St. Rank held Impax Laboratories, Inc. as of Q1 2014.

Based on SEI Trust Company's 13F filing for Q1 2014, filed 28 Apr 2014.